Form 8.3 - Dechra Pharmaceuticals PLC
Global Newswire by Notified: M&A
JULY 24, 2023
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3
75 
E200: Buying or Selling a Small Business? Get the Insider Tips You Need to Secure Your Deal
How2Exit
MARCH 31, 2024
Get the Insider Tips You Need to Secure Your Deal - Watch Here rn rn About the Guest(s): rn Patrick O'Connell is an experienced mergers and acquisitions (M&A) advisor with a profound depth of knowledge in buying and selling small businesses valued between one to $20 million. b' E200: Buying or Selling a Small Business?
Join 47,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Form 8.3 - Dechra Pharmaceuticals PLC
Global Newswire by Notified: M&A
JANUARY 12, 2024
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3
Form 8.3 - Dechra Pharmaceuticals PLC
Global Newswire by Notified: M&A
JANUARY 9, 2024
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3
Form 8.3 - Dechra Pharmaceuticals PLC
Global Newswire by Notified: M&A
JANUARY 3, 2024
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3
Form 8.3 - Dechra Pharmaceuticals PLC
Global Newswire by Notified: M&A
JANUARY 16, 2024
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3
Form 8.3 - Dechra Pharmaceuticals PLC
Global Newswire by Notified: M&A
JANUARY 15, 2024
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3
Let's personalize your content